Impact of chronic potassium binder treatment on the clinical outcomes in patients with hyperkalemia: Results of a nationwide hospital-based cohort study

por Kanda, Eiichiro, Morita, Naru, Yajima, Toshitaka
Publicado 2023

Correction: Kohsaka et al. Risk–Benefit Balance of Renin–Angiotensin–Aldosterone Inhibitor Cessation in Heart Failure Patients with Hyperkalemia. J. Clin. Med. 2022, 11, 5828

por Kohsaka, Shun, Okami, Suguru, Morita, Naru, Yajima, Toshitaka
Publicado 2023

Risk–Benefit Balance of Renin–Angiotensin–Aldosterone Inhibitor Cessation in Heart Failure Patients with Hyperkalemia

por Kohsaka, Shun, Okami, Suguru, Morita, Naru, Yajima, Toshitaka
Publicado 2022

Evolution of sodium-glucose co-transporter 2 inhibitors from a glucose-lowering drug to a pivotal therapeutic agent for cardio-renal-metabolic syndrome

por Akiyama, Hiroki, Nishimura, Akihiro, Morita, Naru, Yajima, Toshitaka
Publicado 2023

Hyperkalemia in Real-World Patients Under Continuous Medical Care in Japan

por Kashihara, Naoki, Kohsaka, Shun, Kanda, Eiichiro, Okami, Suguru, Yajima, Toshitaka
Publicado 2019

Clinical and Economic Burden of Hyperkalemia: A Nationwide Hospital-Based Cohort Study in Japan

por Kanda, Eiichiro, Kashihara, Naoki, Kohsaka, Shun, Okami, Suguru, Yajima, Toshitaka
Publicado 2020

Cardiovascular and Renal Outcomes Associated With Hyperkalemia in Chronic Kidney Disease: A Hospital-Based Cohort Study

por Kohsaka, Shun, Okami, Suguru, Kanda, Eiichiro, Kashihara, Naoki, Yajima, Toshitaka
Publicado 2021

Association of Hyperkalemia and Hypokalemia with Patient Characteristics and Clinical Outcomes in Japanese Hemodialysis (HD) Patients

por Iwagami, Masao, Kanemura, Yuka, Morita, Naru, Yajima, Toshitaka, Fukagawa, Masafumi, Kobayashi, Shuzo
Publicado 2023

Effects of Food on the Pharmacokinetics of Omega-3-Carboxylic Acids in Healthy Japanese Male Subjects: A Phase I, Randomized, Open-label, Three-period, Crossover Trial

por Shimada, Hitoshi, Nilsson, Catarina, Noda, Yoshinori, Kim, Hyosung, Lundström, Torbjörn, Yajima, Toshitaka
Publicado 2017

Manifestation of Heart Failure and Chronic Kidney Disease are Associated with Increased Mortality Risk in Early Stages of Type 2 Diabetes Mellitus: Analysis of a Japanese Real-Worl...

por Kadowaki, Takashi, Komuro, Issei, Morita, Naru, Akiyama, Hiroki, Kidani, Yoko, Yajima, Toshitaka
Publicado 2022

Health Care Cost Analysis of PPI or P-CAB-First Treatment in Patients With Gastroesophageal Reflux Disease

por Miwa, Hiroto, Shiotani, Akiko, Takeda, Masayoshi, Eda, Masahiro, Kato, Toshiaki, Yajima, Toshitaka
Publicado 2022

Efficacy and safety of dapagliflozin in addition to insulin therapy in Japanese patients with type 2 diabetes: Results of the interim analysis of 16‐week double‐blind treatment per...

por Araki, Eiichi, Onishi, Yukiko, Asano, Michiko, Kim, Hyosung, Ekholm, Ella, Johnsson, Eva, Yajima, Toshitaka
Publicado 2016

Machine learning models for prediction of HF and CKD development in early-stage type 2 diabetes patients

por Kanda, Eiichiro, Suzuki, Atsushi, Makino, Masaki, Tsubota, Hiroo, Kanemata, Satomi, Shirakawa, Koichi, Yajima, Toshitaka
Publicado 2022

Cost-Effectiveness Analysis of Initiating Type 2 Diabetes Therapy with a Sodium–Glucose Cotransporter 2 Inhibitor Versus Conventional Therapy in Japan

por Igarashi, Ataru, Maruyama-Sakurai, Keiko, Kubota, Anna, Akiyama, Hiroki, Yajima, Toshitaka, Kohsaka, Shun, Miyata, Hiroaki
Publicado 2022

Baseline Characteristics of Patients with Type 2 Diabetes Initiating Second-Line Treatment in Japan: Findings from the J-DISCOVER Study

por Katakami, Naoto, Mita, Tomoya, Takahara, Mitsuyoshi, Yajima, Toshitaka, Wada, Fumitaka, Kawashima, Masaru, Shimomura, Iichiro, Watada, Hirotaka
Publicado 2020

Sodium–glucose cotransporter 2 inhibitors compared with other glucose‐lowering drugs in Japan: Subanalyses of the CVD‐REAL 2 Study

por Kohsaka, Shun, Takeda, Masayoshi, Bodegård, Johan, Thuresson, Marcus, Kosiborod, Mikhail, Yajima, Toshitaka, Wittbrodt, Eric, Fenici, Peter
Publicado 2020

Machine Learning Models Predicting Cardiovascular and Renal Outcomes and Mortality in Patients with Hyperkalemia

por Kanda, Eiichiro, Okami, Suguru, Kohsaka, Shun, Okada, Masafumi, Ma, Xiaojun, Kimura, Takeshi, Shirakawa, Koichi, Yajima, Toshitaka
Publicado 2022

A phase 3 multicenter open-label maintenance study to investigate the long-term safety of sodium zirconium cyclosilicate in Japanese subjects with hyperkalemia

por Kashihara, Naoki, Yamasaki, Yoshimitsu, Osonoi, Takeshi, Harada, Hiromasa, Shibagaki, Yugo, Zhao, June, Kim, Hyosung, Yajima, Toshitaka, Sarai, Nobuaki
Publicado 2020

Three-Year Glycaemic Control and Management in Patients with Type 2 Diabetes Initiating Second-Line Treatment in Japan: A Prospective Observational Study, J-DISCOVER

por Takahara, Mitsuyoshi, Mita, Tomoya, Katakami, Naoto, Wada, Fumitaka, Morita, Naru, Kidani, Yoko, Yajima, Toshitaka, Shimomura, Iichiro, Watada, Hirotaka
Publicado 2021

Pharmacokinetics and pharmacodynamics of dapagliflozin in combination with insulin in Japanese patients with type 1 diabetes

por Watada, Hirotaka, Shiramoto, Masanari, Ueda, Shinya, Tang, Weifeng, Asano, Michiko, Thorén, Fredrik, Kim, Hyosung, Yajima, Toshitaka, Boulton, David W., Araki, Eiichi
Publicado 2018